AstraZeneca Pharma India Limited (BOM: 506820)

AstraZeneca Pharma India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 9, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	172,656	133,010	81,183	63,886	75,255	59,789
Market Cap Growth	68.07%	63.84%	27.07%	-15.11%	25.87%	19.68%
Enterprise Value	167,646	127,861	76,552	60,484	72,857	57,477
Last Close Price	6906.25	5302.47	3222.61	2529.13	2977.28	2363.99
PE Ratio	180.07	82.08	81.14	102.64	79.78	81.84
PS Ratio	12.44	10.27	8.09	7.93	9.25	7.19
PB Ratio	24.25	18.68	13.79	12.49	16.50	16.41
P/FCF Ratio	-	777.38	163.12	70.07	77.53	81.68
P/OCF Ratio	-	477.25	139.27	63.38	71.82	68.39
EV/Sales Ratio	12.08	9.87	7.63	7.51	8.96	6.91
EV/EBITDA Ratio	106.94	69.81	47.45	73.16	54.94	48.72
EV/EBIT Ratio	117.94	74.58	51.43	87.20	62.67	56.04
EV/FCF Ratio	-	747.29	153.81	66.33	75.06	78.52
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.03	0.03
Debt / EBITDA Ratio	0.03	0.02	0.04	0.10	0.09	0.10
Debt / FCF Ratio	-	0.27	0.14	0.09	0.13	0.16
Asset Turnover	-	1.26	1.09	0.99	1.10	1.31
Inventory Turnover	-	2.87	2.22	2.11	1.85	2.20
Quick Ratio	-	1.89	1.61	1.64	1.46	1.06
Current Ratio	-	2.61	2.18	2.12	2.04	1.66
Return on Equity (ROE)	-	24.84%	18.05%	12.73%	22.74%	21.71%
Return on Assets (ROA)	-	10.39%	10.10%	5.31%	9.81%	10.11%
Return on Capital (ROIC)	13.54%	16.33%	16.67%	8.77%	17.21%	18.93%
Earnings Yield	0.56%	1.21%	1.22%	0.96%	1.24%	1.21%
FCF Yield	0.13%	0.61%	1.43%	1.29%	1.22%
Dividend Yield	0.35%	0.45%	0.50%	0.40%	0.07%	0.04%
Payout Ratio	0.00%	24.77%	20.14%	8.12%	5.36%	3.46%
Total Shareholder Return	0.38%	0.45%	0.50%	0.40%	0.07%	0.04%

Source: S&P Capital IQ. Standard template. Financial Sources.